Skip to Main Content

Paper Details

Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma.
bioRxiv
1
2023
CD163, GBMs, Glioblastomas, LYZ, MACs, MG, TREM2, Trem2, Trem2 MACs, Triggering receptor expressed on myeloid cells 2, WT tumors, ZsGreen, brain tumors, dendritic cells, glioblastoma, glioma, gliomas, human, innate immune cells, low- and high-grade human gliomas, lysozyme, macrophages, mice, microglia, mouse, mouse glioma cell lines, myeloid cell, patient, triggering receptor expressed on myeloid cells 2, tumor, tumors, tumors of the central nervous system
Author NameAffiliation
Brian VaillantDell Medical School, University of Texas at Austin
Jason T HuseDepartment of Translational Molecular Pathology at the University of Texas MD Anderson Cancer Center
Jason T HuseThe University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences
Linghua WangDepartment of Genomic Medicine at the University of Texas MD Anderson Cancer Center
Krishna P BhatDepartment of Translational Molecular Pathology at the University of Texas MD Anderson Cancer Center
Krishna P BhatDepartment of Neurosurgery at the University of Texas MD Anderson Cancer Center
Krishna P BhatThe University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences
  • 1 - 7

Datasets

Release 1.2